APA (7th ed.) Citation

Hardenberg, J. v., Schwartz, M., Worst, T., Nuhn, P., & Heinrich, E. (2017). Oncologic response and hospitalization rate of patients receiving cabazitaxel in the fourth-line and beyond in castration-resistant prostate cancer: Analysis of a retrospective cohort and a structured literature review. Urologia internationalis, 99(4), . https://doi.org/10.1159/000477943

Chicago Style (17th ed.) Citation

Hardenberg, Jost von, Maike Schwartz, Thomas Worst, Philipp Nuhn, and Elmar Heinrich. "Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-line and Beyond in Castration-resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review." Urologia Internationalis 99, no. 4 (2017). https://doi.org/10.1159/000477943.

MLA (9th ed.) Citation

Hardenberg, Jost von, et al. "Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-line and Beyond in Castration-resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review." Urologia Internationalis, vol. 99, no. 4, 2017, https://doi.org/10.1159/000477943.